Tadalafil for ED after transurethral resection of the prostate: a report of 113 cases.
- Author:
Min-jun QI
1
;
Zhi-gang CAO
;
Rui-peng JA
;
Zheng XU
;
Lu-wei XU
;
Jun LIU
;
Jiang-hao SU
Author Information
- Publication Type:Clinical Trial
- MeSH: Aged; Carbolines; therapeutic use; Erectile Dysfunction; drug therapy; etiology; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; therapeutic use; Tadalafil; Transurethral Resection of Prostate; adverse effects; Treatment Outcome
- From: National Journal of Andrology 2011;17(10):894-896
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the efficacy of tadalafil in the treatment of ED after transurethral resection of the prostate (TURP).
METHODSA total of 113 patients with ED after TURP received 3 months of tadalafil treatment and were followed up for 6 months. The IIEF-5 scores of the patients and the number of successful penile intromissions and sustained penile erections in the patients' sexual life diary were compared before and after the treatment.
RESULTSThe IIEF-5 scores were 9.83 +/- 3.96 before the medication, 20.23 +/- 3.25 after it, and 17.28 +/- 3.03 at 6 months after drug withdrawal, with statistically significant differences between pre- and post-treatment (P < 0.05). The patients' success rates of penile intromission and sexual intercourse were increased from 44.8% and 7.5% before the medication to 81.7% and 63.2% after it.
CONCLUSIONTadalafil can be used as a first-line drug for the treatment of ED after TURP.
